The Russian pharmaceutical company will spend more than 4 billion rubles on the construction of a drug production facility in St. Petersburg. An impressive sum of 2.9 billion rubles will be utilized to construct a top-notch facility alongside fitting it with state-of-the-art equipment. Furthermore, the investment of 1.2 billion rubles will be utilized solely for research and development with the aim developing new technologies and techniques.
The project entails the creation of 31 pharmaceutical products, comprising analogues of oncological drugs, drugs for cardiovascular diseases, neurological disorders, and diabetes treatment.
GxP News wrote that R-Pharm plans to build the production of medicines in St. Petersburg by 2026 under the first offset contract. In January, the government of St. Petersburg and R-Pharm signed a contract for a period of 10 years. According to the terms of the contract. After the enterprise is constructed, the municipality will procure medication from the firm for a total of 8.7 billion rubles over the course of seven years.
